10 things I learned about ADCs at AACR 2024
In our fourth AACR 2024 preview we’ve going to highlight some emerging trends you should watch out for. We took a look across over 130 abstracts and in an unbiased fashion, delved into the weeds to see what would shake out.
The findings were interesting to say the least:
Some expected, some unexpected surprises, others puzzling, a few provocative ones made me stop and think more about their approach.
It’s all here, black and white…
To continue reading our latest highlights on oncology new product development including commentary and analysis BSB subscribers can log-in or you can click to access the content.
This content is restricted to subscribers